AI in Pharma Supply Chain Market Size, Share, and Trends 2026 to 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on AI in Pharma Supply Chain Market 

5.1. COVID-19 Landscape: AI in Pharma Supply Chain Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global AI in Pharma Supply Chain Market, By Deployment Mode

8.1. AI in Pharma Supply Chain Market, by Deployment Mode

8.1.1. Cloud-based

8.1.1.1. Market Revenue and Forecast

8.1.2. On premises

8.1.2.1. Market Revenue and Forecast

Chapter 9. Global AI in Pharma Supply Chain Market, By Technology

9.1. AI in Pharma Supply Chain Market, by Technology

9.1.1. Machine Learning

9.1.1.1. Market Revenue and Forecast

9.1.2. Predictive Analytics

9.1.2.1. Market Revenue and Forecast

9.1.3. Natural Language Processing (NLP)

9.1.3.1. Market Revenue and Forecast

9.1.4. Computer Vision

9.1.4.1. Market Revenue and Forecast

9.1.5. Robotic Process Automation (RPA)

9.1.5.1. Market Revenue and Forecast

Chapter 10. Global AI in Pharma Supply Chain Market, By Application 

10.1. AI in Pharma Supply Chain Market, by Application

10.1.1. Demand Forecasting

10.1.1.1. Market Revenue and Forecast

10.1.2. Inventory Management

10.1.2.1. Market Revenue and Forecast

10.1.3. Warehouse Automation

10.1.3.1. Market Revenue and Forecast

10.1.4. Logistics Optimization

10.1.4.1. Market Revenue and Forecast

10.1.5. Cold Chain Monitoring

10.1.5.1. Market Revenue and Forecast

10.1.6. Risk & Compliance Management

10.1.6.1. Market Revenue and Forecast

Chapter 11. Global AI in Pharma Supply Chain Market, By End-Use 

11.1. AI in Pharma Supply Chain Market, by End-Use

11.1.1. Pharmaceutical Manufacturers

11.1.1.1. Market Revenue and Forecast

11.1.2. Biotechnology Companies

11.1.2.1. Market Revenue and Forecast

11.1.3. Contract Manufacturing Organizations (CMOs)

11.1.3.1. Market Revenue and Forecast

11.1.4. Distributors & Logistics Providers

11.1.4.1. Market Revenue and Forecast

Chapter 12. Global AI in Pharma Supply Chain Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Deployment Mode

12.1.2. Market Revenue and Forecast, by Technology

12.1.3. Market Revenue and Forecast, by Application

12.1.4. Market Revenue and Forecast, by End-Use

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Deployment Mode

12.1.5.2. Market Revenue and Forecast, by Technology

12.1.5.3. Market Revenue and Forecast, by Application

12.1.5.4. Market Revenue and Forecast, by End-Use

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Deployment Mode

12.1.6.2. Market Revenue and Forecast, by Technology

12.1.6.3. Market Revenue and Forecast, by Application

12.1.6.4. Market Revenue and Forecast, by End-Use

12.2. Europe

12.2.1. Market Revenue and Forecast, by Deployment Mode

12.2.2. Market Revenue and Forecast, by Technology

12.2.3. Market Revenue and Forecast, by Application

12.2.4. Market Revenue and Forecast, by End-Use

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Deployment Mode

12.2.5.2. Market Revenue and Forecast, by Technology

12.2.5.3. Market Revenue and Forecast, by Application

12.2.5.4. Market Revenue and Forecast, by End-Use

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Deployment Mode

12.2.6.2. Market Revenue and Forecast, by Technology

12.2.6.3. Market Revenue and Forecast, by Application

12.2.6.4. Market Revenue and Forecast, by End-Use

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Deployment Mode

12.2.7.2. Market Revenue and Forecast, by Technology

12.2.7.3. Market Revenue and Forecast, by Application

12.2.7.4. Market Revenue and Forecast, by End-Use

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Deployment Mode

12.2.8.2. Market Revenue and Forecast, by Technology

12.2.8.3. Market Revenue and Forecast, by Application

12.2.8.4. Market Revenue and Forecast, by End-Use

12.3. APAC

12.3.1. Market Revenue and Forecast, by Deployment Mode

12.3.2. Market Revenue and Forecast, by Technology

12.3.3. Market Revenue and Forecast, by Application

12.3.4. Market Revenue and Forecast, by End-Use

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Deployment Mode

12.3.5.2. Market Revenue and Forecast, by Technology

12.3.5.3. Market Revenue and Forecast, by Application

12.3.5.4. Market Revenue and Forecast, by End-Use

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Deployment Mode

12.3.6.2. Market Revenue and Forecast, by Technology

12.3.6.3. Market Revenue and Forecast, by Application

12.3.6.4. Market Revenue and Forecast, by End-Use

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Deployment Mode

12.3.7.2. Market Revenue and Forecast, by Technology

12.3.7.3. Market Revenue and Forecast, by Application

12.3.7.4. Market Revenue and Forecast, by End-Use

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Deployment Mode

12.3.8.2. Market Revenue and Forecast, by Technology

12.3.8.3. Market Revenue and Forecast, by Application

12.3.8.4. Market Revenue and Forecast, by End-Use

12.4. MEA

12.4.1. Market Revenue and Forecast, by Deployment Mode

12.4.2. Market Revenue and Forecast, by Technology

12.4.3. Market Revenue and Forecast, by Application

12.4.4. Market Revenue and Forecast, by End-Use

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Deployment Mode

12.4.5.2. Market Revenue and Forecast, by Technology

12.4.5.3. Market Revenue and Forecast, by Application

12.4.5.4. Market Revenue and Forecast, by End-Use

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Deployment Mode

12.4.6.2. Market Revenue and Forecast, by Technology

12.4.6.3. Market Revenue and Forecast, by Application

12.4.6.4. Market Revenue and Forecast, by End-Use

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Deployment Mode

12.4.7.2. Market Revenue and Forecast, by Technology

12.4.7.3. Market Revenue and Forecast, by Application

12.4.7.4. Market Revenue and Forecast, by End-Use

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Deployment Mode

12.4.8.2. Market Revenue and Forecast, by Technology

12.4.8.3. Market Revenue and Forecast, by Application

12.4.8.4. Market Revenue and Forecast, by End-Use

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Deployment Mode

12.5.2. Market Revenue and Forecast, by Technology

12.5.3. Market Revenue and Forecast, by Application

12.5.4. Market Revenue and Forecast, by End-Use

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Deployment Mode

12.5.5.2. Market Revenue and Forecast, by Technology

12.5.5.3. Market Revenue and Forecast, by Application

12.5.5.4. Market Revenue and Forecast, by End-Use

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Deployment Mode

12.5.6.2. Market Revenue and Forecast, by Technology

12.5.6.3. Market Revenue and Forecast, by Application

12.5.6.4. Market Revenue and Forecast, by End-Use

Chapter 13. Company Profiles

13.1. IBM

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. SAP

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Oracle

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Microsoft

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Kinaxis

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Blue Yonder

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Infor

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Logility

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. project44

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. o9 Solutions

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms